Skip to main content

Table 5 Quality of life values assigned to health states

From: Cost-effectiveness of prostate cancer screening: a systematic review of decision-analytical models

Study Starting state Diagnosis Treatment Other Advanced End of life Adverse effects
Biopsy Cancer Short- term Long-term
Chilcott, Hummel [23] Baseline = age dependent     0.635   Bowel function = 0.89
Urinary function = 0.94
Sexual dysfunction =0.9
Heijnsdijk et al. [25] Screening = 0.99 0.9 0.8 Radiation = 0.73 Radiation = 0.78 Post-recovery = 0.95 0.6 0.4 Short-term & long-term effect
    Prostatectomy = 0.67 Prostatectomy = 0.77    
    Active surveillance = 0.97 Active surveillance = 0.97    
Hummel and Chilcott [24] Baseline = age dependent       0.635   Bowel function = 0.89
Urinary function = 0.94
Sexual dysfunction =0.9
Keller et al. [29] age dependent/ screening = 1.0    0.95b 0.95b   0.9 to >0.6b   See treatment: Persistent effects, 3 years post-diagnosis
Kobayashi et al. [27]       Curable = 0.9
Recurrent = 0.7
0.5   See curable: impotence & incontinence
Martin et al. [30]    0.95a      0.5 See cancer
Pataky et al. [26] Healthy screening population = 1.0    0.88 0.9 Symptomatic =0.9 0.85 0.5 Short-term & long-term effect
Roth et al. [28] Healthy screening population = 1.0    0.75 0.92 Symptomatic =0.89 0.75 0.33 Short-term & long-term effect
    Surveillance = 0.92 Surveillance = 0.92    
  1. a Diagnosed and treated. bmultipliers of age dependent baseline value